![shape-element-one[1]](https://ambrygen.com/wp-content/uploads/2026/03/shape-element-one1.svg)
![shape-element-two[1]](https://ambrygen.com/wp-content/uploads/2026/03/shape-element-two1.svg)
Licenses
Ambry Genetics is both CAP-accredited and CLIA-approved. Ambry is able to conduct genetic testing on samples received from any state in the US. In addition, Ambry has special licensure from the states listed below.
Licensing & Regulatory
- CAP Accredited (Oct 26, 2026)
- CLIA Approved (May 29, 2028)
- State of California (Oct 17, 2026)
- State of Maryland
- State of New York (June 30, 2027)
- State of Pennsylvania (Aug 15, 2027)
- State of Rhode Island (Dec 30, 2027)
Proficiency Testing
Ambry Genetics participates in Proficiency Testing provided by the College of American Pathologists (CAP) for all available tests and performs Alternative Proficiency Testing where CAP does not provide an offering.